Free Trial

Johnson & Johnson Top Holdings and 13F Report (2023)

About Johnson & Johnson

Johnson & Johnson NYSE: JNJ has filed 13-F forms with the SEC as an investor. Johnson & Johnson is itself a publicly traded company. Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. For more information on Johnson & Johnson stock, visit the Johnson & Johnson stock profile here.

Investment Activity

  • Johnson & Johnson has $652.36 million in total holdings as of December 31, 2022.
  • Johnson & Johnson owns shares of 16 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • Approximately 0.21% of the portfolio was purchased this quarter.
  • About 0.67% of the portfolio was sold this quarter.
  • This quarter, Johnson & Johnson has purchased 17 new stocks and bought additional shares in 0 stocks.
  • Johnson & Johnson sold shares of 1 stock and completely divested from 2 stocks this quarter.

Largest Holdings

Nanobiotix
$173,607,200
MeiraGTx
$57,511,614
Rapport Therapeutics, Inc.
$55,837,537
CVRx
$38,075,185

Largest New Holdings this Quarter

75120L209 - Rallybio Corporation
$1,371,522 Holding

Largest Purchases this Quarter

Rallybio Corporation
152,901 shares (about $1.37M)

Largest Sales this Quarter

Nano-X Imaging
75,298 shares (about $170.93K)

Sector Allocation Over Time

Map of 500 Largest Holdings ofJohnson & Johnson

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
$258,143,8880.0%2,449,18339.6%Medical
Nanobiotix S.A. - Sponsored ADR stock logo
NBTX
Nanobiotix
$173,607,2000.0%5,623,81626.6%Medical
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
$57,511,6140.0%6,641,0648.8%Medical
Rapport Therapeutics, Inc.
$55,837,5370.0%1,784,5178.6%COM
CVRx, Inc. stock logo
CVRX
CVRx
$38,075,1850.0%4,024,8615.8%Medical
Contineum Therapeutics Inc.
$25,847,9990.0%1,979,1734.0%CL A
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$14,735,8610.0%814,5862.3%Medical
Xencor, Inc. stock logo
XNCR
Xencor
$9,021,6280.0%748,0621.4%Medical
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$8,952,0540.0%357,9391.4%Medical
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
$4,054,8770.0%3,379,0640.6%Medical
Neumora Therapeutics, Inc.
$3,606,4180.0%1,849,4450.6%COM
Rallybio Corporation
$1,371,522$1,371,522 â–²New Holding152,9010.2%COM
Vor Biopharma, Inc.
$958,5790.0%53,7320.1%COM NEW
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$286,7910.0%311,9670.0%Medical
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$189,668$170,927 â–¼-47.4%83,5540.0%Business Services
Adicet Bio, Inc.
$155,1250.0%22,7790.0%COM NEW
Rallybio Corporation stock logo
RLYB
Rallybio
$0$2,494,909 â–¼-100.0%00.0%Medical
Lyell Immunopharma, Inc.
$0$1,689,422 â–¼-100.0%00.0%COM NEW

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data